Cited by 1,140Cancer, Hypoxia, and MetabolismDNA Repair MechanismsCell death mechanisms and regulation

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Hypoxia, DNA repair and genetic instability

Bristow, Robert G., Hill, Richard P.·2008·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Areas of hypoxic tumour tissue are known to be resistant to treatment and are associated with a poor clinical prognosis. There are several reasons why this might be, including the capacity of hypoxia to drive genomic instability and alter DNA damage repair pathways. Significantly, current models fail to distinguish between the complexities of the hypoxic microenvironment and the biological effects of acute hypoxia exposures versus longer-term, chronic hypoxia exposures on the transcription and translation of proteins involved in genetic stability and cell survival. Acute and chronic hypoxia might lead to different biology within the tumour and this might have a direct effect on the design of new therapies for the treatment of hypoxic tumours.

Integrity signals

Registry

Crossref · 10.1038/nrc2344

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Regulation of hypoxia-inducible factor 1α is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 1×
“When tissue metabolism exceeds metabolic supply, as is the case for most tumours, the hypoxic response leads to a series of changes in protein expression to protect against cell deat”
Background

Flagged first, then by citations

Show all 112 references

Sorted by citations

Items 401–500 of 1,000

Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC)
Vigneswaran, N., Wu, J. G., Song, A., Annapragada, A., & Zacharias, W. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.11.011 · Cited by 40
Expression and hypoxic up‐regulation of neuroglobin in human glioblastoma cells
Emara, M., Salloum, N., & Allalunis‐Turner, J. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.11.002 · Cited by 40
Acute and chronic in vivo therapeutic resistance
Teicher, B. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.006 · Cited by 40
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours
Menegakis, A., Eicheler, W., Yaromina, A., Thames, H. D., Krause, M., & Baumann, M. A. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.001 · Cited by 41
TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy
Zheng, R., Yao, Q., Xie, G., Du, S., Ren, C., Wang, Y., & Yuan, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4002 · Cited by 40
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI
Panek, R., Welsh, L. C., Baker, L. C. J., Schmidt, M. A., Wong, K. H., Riddell, A. M., Koh, D., Dunlop, A., Mcquaid, D., d’Arcy, J. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1209 · Cited by 40
Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy
Potiron, V. A., Clément-Colmou, K., Jouglar, E., Pietri, M., Chiavassa, S., Delpon, G., Paris, F., & Supiot, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.005 · Cited by 41
Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia
Rickard, A. G., Palmer, G. M., & Dewhirst, M. W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_2 · Cited by 41
A Multimodal Therapeutic Nanoplatform Overcoming Tumor Hypoxia Heterogeneity for Improved Tumor Chemoradiotherapy
Zhang, L., Du, X., Li, Q., Qian, L., Chen, J., Liu, C., Yu, Q., & Gan, Z. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204629 · Cited by 40
Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors
Chaudary, N., & Hill, R. P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.16 · Cited by 40
Self-citation
An Essential Role of the HIF‐1α–c‐Myc Axis in Malignant Progression
Yoo, Y., Hayashi, M., Christensen, J., & Huang, E. L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05043.x · Cited by 41
Molecular radiation biology: Perspectives for radiation oncology
Rodemann, H. P. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.08.023 · Cited by 40
Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeutics
Das, B. C., Madhukumar, A. V., Anguiano, J., & Mani, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.110 · Cited by 40
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
He, Z., Hu, X., Liu, W., Dorrance, A. M., Garzon, R., Houghton, P. J., & Shen, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17440 · Cited by 41
Hsc70 Contributes to Cancer Cell Survival by Preventing Rab1A Degradation under Stress Conditions
Tanaka, M., Mun, S., Harada, A., Ohkawa, Y., Inagaki, A., Sano, S., Takahashi, K., Izumi, Y., Osada‐Oka, M., Wanibuchi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096785 · Cited by 40
Optimization of PEG coated nanoscale gold particles for enhanced radiation therapy
Cruje, C., Yang, C. J., Uertz, J., van Prooijen, M., & Chithrani, D. B. (2015) · RSC Advances · doi:10.1039/c5ra19104a · Cited by 40
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 39
Therapeutic Potential of the miRNA–ATM Axis in the Management of Tumor Radioresistance
Rezaeian, A.-H., Khanbabaei, H., & Călin, G. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1807 · Cited by 40
A Paradigm Revolution or Just Better Resolution—Will Newly Emerging Superresolution Techniques Identify Chromatin Architecture as a Key Factor in Radiation-Induced DNA Damage and Repair Regulation?
Falk, M., & Hausmann, M. (2020) · Cancers · doi:10.3390/cancers13010018 · Cited by 39
5′‐AMP‐activated protein kinase activity is elevated early during primary brain tumor development in the rat
Jang, T., Calaoagan, J. M., Kwon, E. E., Samuelsson, S. J., Recht, L. D., & Laderoute, K. R. (2010) · International Journal of Cancer · doi:10.1002/ijc.25558 · Cited by 39
Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T
Ramaekers, C. H. M. A., van den Beucken, T., Meng, A. X., Kassam, S. N., Thoms, J., Bristow, R. G., & Wouters, B. G. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.059 · Cited by 39
Self-citation
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Moustafa, A. A., & Mallei, M. I. (2021) · doi:10.1201/9781003180449-12 · Cited by 40
Prolyl Hydroxylase-dependent Modulation of Eukaryotic Elongation Factor 2 Activity and Protein Translation under Acute Hypoxia
Romero‐Ruíz, A., Borrego, L. B., Navarro, V., Heras‐Garvin, A., March‐Díaz, R., Castellano, A., Gómez‐Díaz, R., Castro, M. J., Berra, E., López‐Barneo, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299180 · Cited by 38
Tumors as Organs: Biologically Augmenting Radiation Therapy by Inhibiting Transforming Growth Factor β Activity in Carcinomas
Du, S., & Barcellos‐Hoff, M. H. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.001 · Cited by 38
Prediction of Tumour Tissue Diffusion Coefficients of Hypoxia-Activated Prodrugs from Physicochemical Parameters
Pruijn, F. B., Patel, K., Hay, M. P., Wilson, W. R., & Hicks, K. O. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08240 · Cited by 38
Cell physiology regulation by hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells
Eskandani, M., Vandghanooni, S., Barar, J., Nazemiyeh, H., & Omidi, Y. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.113 · Cited by 40
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
Skwarska, A., Calder, E. D. D., Sneddon, D., Bolland, H. R., Odyniec, M. L., Mistry, I. N., Martin, J., Folkes, L. K., Conway, S. J., & Hammond, E. M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.004 · Cited by 38
Emerging evidence of the physiological role of hypoxia in mammary development and lactation
Shao, Y., & Zhao, F. (2014) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/2049-1891-5-9 · Cited by 40
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2–ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
Ko, J., Tsai, M., Weng, S., Kuo, Y., Chiu, Y., & Lin, Y. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.012 · Cited by 37
New Challenges and Inspired Answers for Anticancer Drug Discovery and Development
Utsugi, T. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt131 · Cited by 37
Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes
Han, K. C.-Z., Pintilie, M., Lipscombe, L. L., Lega, I. C., Milosevic, M., & Fyles, A. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1008 · Cited by 37
Resistance to DNA damage and enhanced DNA repair capacity in the hypoxia-tolerant blind mole rat, Spalax
Domankevich, V., Eddini, H., Odeh, A., & Shams, I. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.174540 · Cited by 37
Hipoxia tumoral. Papel del factor inducible por hipoxia
Fraga, A. M., Ribeiro, R. J. T., & Medeiros, R. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)72891-8 · Cited by 37
Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma
Kato, H., Ito, E., Shi, W., Alajez, N. M., Yue, S., Lee, C., Chan, N. H. L., Bhogal, N., Coackley, C. L., Vines, D., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1945 · Cited by 37
Self-citation
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
Abbattista, M. R., Jamieson, S. M. F., Gu, Y., Nickel, J. E., Pullen, S. M., Patterson, A. V., Wilson, W. R., & Guise, C. P. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1017171 · Cited by 36
Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer
Yang, J., Wu, Z., Chen, Y., Hu, C., Li, D., Chen, Y., İmani, S., Wen, Q., Fu, S., & Wu, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03434-0 · Cited by 36
Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients
Balázs, K., Antal, L., Sáfrány, G., & Lumniczky, K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040296 · Cited by 37
Aggregation‐Induced Emission Gold Clustoluminogens for Enhanced Low‐Dose X‐ray‐Induced Photodynamic Therapy
Sun, W., Luo, L., Feng, Y., Cai, Y., Zhuang, Y., Xie, R., Chen, X. S., & Chen, H. (2019) · Angewandte Chemie · doi:10.1002/ange.201908712 · Cited by 36
A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer
Han, K. C.-Z., Fyles, A., Shek, T. L. T., Croke, J. M., Dhani, N. C., D'Souza, D. P., Lee, T., Chaudary, N., Bruce, J. P., Pintilie, M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1665 · Cited by 36
Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer
Liu, X., Kifle, M. T., Xie, H., Xu, L., Luo, M., Li, Y., Huang, Z., Gong, Y. Q., Wu, Y., & Xie, C. (2022) · Nanomaterials · doi:10.3390/nano12183138 · Cited by 36
Targeting DNA repair and the cell cycle in glioblastoma
Alexander, B. M., Pinnell, N. E., Wen, P. Y., & D’Andrea, A. D. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0765-4 · Cited by 38
Hypoxia-induced upregulation of Orai1 drives colon cancer invasiveness and angiogenesis
Liu, X., Wan, X., Kan, H., Wang, Y., Fan, Y., Feng, L., Jin, J., Zhang, P., & Ma, X. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.008 · Cited by 38
Nuclear translocation of Gasdermin D sensitizes colorectal cancer to chemotherapy in a pyroptosis-independent manner
Peng, X., Na, R., Zhou, W., Meng, X., Yang, Y., Amini, S., & Song, L. (2022) · Oncogene · doi:10.1038/s41388-022-02503-7 · Cited by 36
Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer
Sharma, R., & Malviya, R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188869 · Cited by 35
ATM activation in hypoxia - causes and consequences
Olcina, M. M., Grand, R. J. A., & Hammond, E. M. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29903 · Cited by 37
Multiscale modeling of the causal functional roles of nsSNPs in a genome-wide association study: application to hypoxia
Xie, L., Ng, C., Ali, T. A., Valencia, R., Ferreira, B. L., Xue, V., Tanweer, M., Zhou, D., Haddad, G. G., Bourne, P. E., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s3-s9 · Cited by 35
The changing paradigm of tumour response to irradiation
Hill, R. P. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160474 · Cited by 38
Self-citation
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
Jackson, R. K., Liew, L. P., & Hay, M. P. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.004 · Cited by 36
Lost in application: Measuring hypoxia for radiotherapy optimisation
Thiruthaneeswaran, N., Bibby, B. A. S., Yang, L., Hoskin, P., Bristow, R. G., Choudhury, A., & West, C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.039 · Cited by 35
Self-citation
Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy
Noori–Daloii, M. R., Momeny, M., Yousefi, M., Golsaz‐Shirazi, F., Yaseri, M., Motamed, N., Kazemialiakbar, N., & Hashemi, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9603-3 · Cited by 35
Biomarkers for DNA DSB inhibitors and radiotherapy clinical trials
Liu, S. K., Olive, P. L., & Bristow, R. G. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9137-8 · Cited by 35
Self-citation
18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
Chang, E., Liu, H., Unterschemmann, K., Ellinghaus, P., Liu, S., Gekeler, V., Cheng, Z., Berndorff, D., & Gambhir, S. S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0217 · Cited by 35
Radiosensitivity of Cancer-Initiating Cells and Normal Stem Cells (or what the Heisenberg Uncertainly Principle has to do with Biology)
Woodward, W. A., & Bristow, R. G. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.003 · Cited by 35
Self-citation
Intratumoral Hypoxia as the Genesis of Genetic Instability and Clinical Prognosis in Prostate Cancer
Taiakina, D., Pra, A. D., & Bristow, R. G. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_9 · Cited by 34
Self-citation
Bone invasion by oral squamous cell carcinoma: Molecular alterations leading to osteoclastogenesis – a review of literature
Vaassen, L. A. A., Speel, E. M., & Kessler, P. A. W. H. (2017) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2017.04.012 · Cited by 34
Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
Kordbacheh, F., & Farah, C. S. (2021) · Cancers · doi:10.3390/cancers13215471 · Cited by 34
Guanylyl Cyclase C in Colorectal Cancer: Susceptibility Gene and Potential Therapeutic Target
Lin, J. E., Li, P., Pitari, G. M., Schulz, S., & Waldman, S. A. (2009) · Future Oncology · doi:10.2217/fon.09.14 · Cited by 35
p53 Ser15 phosphorylation disrupts the p53–RPA70 complex and induces RPA70-mediated DNA repair in hypoxia
Madan, E., Gogna, R., & Pati, U. (2012) · Biochemical Journal · doi:10.1042/bj20111627 · Cited by 35
Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response
Memon, D., Dawson, K., Smowton, C., Wei, X., Dive, C., & Miller, C. J. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.20 · Cited by 36
S-Phase Cells Are More Sensitive to High-Linear Energy Transfer Radiation
Wang, H., Liu, S., Zhang, P., Zhang, S., Naidu, M. D., Wang, H., & Wang, Y. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.089 · Cited by 34
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
Ishkanian, A., Zafarana, G., Thoms, J., & Bristow, R. G. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.499371 · Cited by 33
Self-citation
Reoxygenation during radiotherapy in intermediate-risk prostate cancer
Supiot, S., Rousseau, C., Dore, M., Rest, C. C. L., Kandel-Aznar, C., Potiron, V. A., Guerif, S. G., Paris, F., Ferrer, L., Campion, L., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.12.022 · Cited by 33
A Near-Infrared Phosphorescent Nanoprobe Enables Quantitative, Longitudinal Imaging of Tumor Hypoxia Dynamics during Radiotherapy
Zheng, X., Cui, L., Chen, M., Soto, L. A. C., Graves, E. E., & Rao, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0530 · Cited by 33
Pharmacogenomics in non-small-cell lung cancer chemotherapy
Danesi, R., Pasqualetti, G., Giovannetti, E., Crea, F., Altavilla, G., Tacca, M. D., & Rosell, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.001 · Cited by 33
Transcriptome Sequencing of the Blind Subterranean Mole Rat, Spalax galili: Utility and Potential for the Discovery of Novel Evolutionary Patterns
Malik, A., Korol, A., Hübner, S., Hernandez, A. G., Thimmapuram, J., Ali, S., Glaser, F., Paz, A., Avivi, A., & Band, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021227 · Cited by 33
Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1
Arnason, T., & Harkness, T. A. A. (2015) · Cancers · doi:10.3390/cancers7040877 · Cited by 33
Dynamic Regulation of Rad51 by E2F1 and p53 in Prostate Cancer Cells upon Drug-Induced DNA Damage under Hypoxia
Wu, M., Wang, X., McGregor, N., Pienta, K. J., & Zhang, J. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.090688 · Cited by 33
HIF ‐2α regulates non‐canonical glutamine metabolism via activation of PI 3K/ mTORC 2 pathway in human pancreatic ductal adenocarcinoma
Li, W., Chen, C., Zhao, X., Ye, H., Zhao, Y., Fu, Z., Pan, W., Zheng, S., Wei, L., Nong, T., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13202 · Cited by 35
A microfluidic gradient generator to simulate the oxygen microenvironment in cancer cell culture
Orcheston-Findlay, L., Hashemi, A., Garrill, A., & Nock, V. (2018) · Microelectronic Engineering · doi:10.1016/j.mee.2018.04.011 · Cited by 32
Review of possible mechanisms of radiotherapy resistance in cervical cancer
Zhang, H., Wang, X., Ma, Y., Zhang, Q., Liu, R., Luo, H., & Wang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164985 · Cited by 32
A unifying theory of carcinogenesis, and why targeted therapy doesn’t work
Gillies, R. J., Flowers, C. I., Drukteinis, J. S., & Gatenby, R. A. (2012) · European Journal of Radiology · doi:10.1016/s0720-048x(12)70018-9 · Cited by 32
Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells
Kang (2010) · International Journal of Oncology · doi:10.3892/ijo_00000714 · Cited by 32
Bad neighbours: hypoxia and genomic instability in prostate cancer
Ashton, J., & Bristow, R. G. (2020) · British Journal of Radiology · doi:10.1259/bjr.20200087 · Cited by 32
Self-citation
Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164046 · Cited by 34
ATM-dependent phosphorylation of 53BP1 in response to genomic stress in oxic and hypoxic cells
Harding, S. M., Coackley, C. L., & Bristow, R. G. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.039 · Cited by 32
Self-citation
Evolution of genetic instability in heterogeneous tumors
Asatryan, A. D., & Komarova, N. L. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.11.028 · Cited by 32
RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature
Viollet, C., Davis, D. A., Tekeste, S. S., Reczko, M., Ziegelbauer, J. M., Pezzella, F., Ragoussis, J., & Yarchoan, R. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006143 · Cited by 32
High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone
Milosevic, M., Pintilie, M., Hedley, D. W., Bristow, R. G., Wouters, B. G., Oza, A. M., Laframboise, S., Hill, R. P., & Fyles, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28403 · Cited by 31
Self-citation
Genetic Differences in Transcript Responses to Low-Dose Ionizing Radiation Identify Tissue Functions Associated with Breast Cancer Susceptibility
Snijders, A. M., Marchetti, F., Bhatnagar, S., Duru, N., Han, J., Hu, Z., Mao, J., Gray, J. W., & Wyrobek, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045394 · Cited by 31
DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment
Saitoh, T., & Oda, T. (2021) · Cancers · doi:10.3390/cancers13030504 · Cited by 31
Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy
Choi, S., Hong, S. P., Bae, J. H., Suh, S. H., Bae, H., Kang, K. P., Lee, H. J., & Koh, G. Y. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000075 · Cited by 31
Multistage‐Responsive Dual‐Enzyme Nanocascades for Synergistic Radiosensitization‐Starvation Cancer Therapy
Zhao, M. H., Zhu, A., Zheng, X., Qian, X., Zhang, S. J., Wu, C., Yu, C., Zhang, J., & Li, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300118 · Cited by 31
Identification of functionally related genes using data mining and data integration: a breast cancer case study
Mosca, E., Bertoli, G. R., Piscitelli, E., Vilardo, L., Reinbold, R. A., Zucchi, I., & Milanesi, L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s12-s8 · Cited by 31
A Cresyl Violet‐Based Fluorescent Off–On Probe for the Detection and Imaging of Hypoxia and Nitroreductase in Living Organisms
Wan, Q., Gao, X., He, X., Chen, S., Song, Y., Gong, Q., Li, X., & Ma, H. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201402364 · Cited by 31
Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1
Pires, I. M., Bencokova, Z., McGurk, C., & Hammond, E. M. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12059 · Cited by 31
Quiescence: a mechanism for escaping the effects of drug on cell populations
Alarcón, T., & Jensen, H. J. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0130 · Cited by 31
Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1α in Hypoxia
Chen, R.-Q., Yang, Q., Chen, Y., Oliveira, V. A., Dalton, W. S., Fearns, C., & Lee, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014316 · Cited by 30
Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: Ten Years of Clinical Experience in Relation to International Guidelines
Hjerpe, A., Own, S. A., & Dobra, K. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0020-ra · Cited by 30
Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer
Shah, V. M., Nguyen, D. X., Fatease, A. M. A., Patel, P. B., Cote, B., Woo, Y., Gheewala, R., Pham, Y., Huynh, M. G., Gannett, C., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.021 · Cited by 30
Tumor Microenvironment – Selective Pressures Boosting Cancer Progression
Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_2 · Cited by 33
Regulation of DNA duplication by the mTOR signaling pathway
He, Z., Houghton, P. J., Williams, T. M., & Shen, C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1897271 · Cited by 30
Understanding the role of potential pathways and its components including hypoxia and immune system in case of oral cancer
Bajrai, L. H., Sohrab, S. S., Mobashir, M., Kamal, M. A., Rizvi, M. M. A., & Azhar, E. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-98031-7 · Cited by 30
Hypoxia disrupt tight junctions and promote metastasis of oral squamous cell carcinoma via loss of par3
Kim, S., Park, S., Moon, E.-H., Kim, G. J., & Choi, J. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02924-8 · Cited by 30
Electron transfer-based combination therapy of cisplatin with tetramethyl- p -phenylenediamine for ovarian, cervical, and lung cancers
Luo, T., Yu, J. J., Nguyen, J. M., Wang, C.-R., Bristow, R. G., Jaffray, D. A., Zhou, X. Z., Lu, K. P., & Lu, Q. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203451109 · Cited by 33
Self-citation
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma
Bache, M., Rot, S., Keßler, J., Güttler, A., Wichmann, H., Greither, T., Wach, S., Taubert, H. W., Söling, A., Bilkenroth, U., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3932 · Cited by 30
ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma
Schrama, D., Scherer, D., Schneider, M. O., Zapatka, M., Bröcker, E., Schadendorf, D., Ugurel, S., Kumar, R., & Becker, J. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.35 · Cited by 30
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Keir, S. T., Dewhirst, M. W., Kirkpatrick, J. P., Bigner, D. D., & Batinic̈‐Haberle, I. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795255957 · Cited by 30
Chloroquine-Mediated Cell Death in Metastatic Pancreatic Adenocarcinoma Through Inhibition of Autophagy
Frieboes, H. B., Huang, J. S., Yin, W., & McNally, L. R. (2013) · PubMed · doi:10.6092/1590-8577/1900 · Cited by 31
A novel steroidal inhibitor of estrogen-related receptor α (ERRα)
Duellman, S. J., Calaoagan, J. M., Sato, B., Fine, R., Klebansky, B., Chao, W., Hobbs, P. D., Collins, N., Sambucetti, L. C., & Laderoute, K. R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.024 · Cited by 30

Authors: Bristow, R. G., & Hill, R. P.
Affiliations: University Health Network (CA)
Corresponding author: Bristow, Robert G.
ORCID: Bristow, Robert G.
Hill, Richard P.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 8
Issue: 3
Pages: 180-192
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2344
OpenAlex: W2012276721
Cited by: 1,140
References: 112
Citations by year: 2026: 29 · 2025: 60 · 2024: 44 · 2023: 51 · 2022: 75 · 2021: 86 · 2020: 70 · 2019: 70 · 2018: 78 · 2017: 66 · 2016: 54 · 2015: 50 · 2014: 63 · 2013: 66 · 2012: 73
FWCI: 4.89
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Cancer Institute
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: chronic hypoxia, acute hypoxia, genomic instability, DNA repair, treatment resistance, cancer prognosis, cancer therapy design
MeSH terms: Animals, Hypoxia, DNA Damage, DNA Repair, Humans, Models, Biological, Neoplasm Metastasis, Neoplasms, Phenotype, Transcription, Genetic, Protein Biosynthesis, Gene Expression Regulation, Neoplastic, Disease Progression, Genomic Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia, DNA repair and genetic instability

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks